As open source becomes more prevalent in clinical research, key issues around open source technology are highlighted at leading industry events.
Washington, DC (PRWEB) June 11, 2010 -- Open source software will be a featured topic at this year’s annual meeting of the Drug Information Association (DIA). The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products.
The largest provider of commercial open source clinical trials software, Akaza Research LLC, will be exhibiting and demonstrating the latest edition of their popular OpenClinica software at Booth #1944. OpenClinica is the world’s leading open source software for electronic data capture (EDC) and clinical data management. Cal Collins, the CEO of Akaza Research, will join other industry executives in panel discussion titled “Utilizing and Integrating Open Source Software in Clinical Research Environments.” Accompanying Mr. Collins will be Mark Paul, CEO of Statworks Inc., and Mark Adams, Project Manager of the NCI’s Cancer Biomedical Informatics Grid (caBIG) and Principal at Booz Allen Hamilton. The session will use real-world case studies to explore how open source software enhances flexibility, interoperability, and cost in clinical trials, and will take place on Thursday, June 17 at 8:30 in Room 152B.
About the Drug Information Association (DIA)
DIA is a neutral, global, professional, member-driven association of nearly 18,000 industry, academia, and regulatory professionals involved in the discovery and development of pharmaceuticals, medical devices, and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.
OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports 21 CFR Part 11, and other regulatory guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. OpenClinica’s open source pricing model facilities a dramatically lower cost of use and ownership than proprietary, closed EDC and data management systems. All versions of OpenClinica are available for free download from http://www.openclinica.org.
About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Waltham, Massachusetts. In collaboration with the 10,000 member OpenClinica open source community, Akaza has developed and commercialized OpenClinica under a professional open source model. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making a robust, flexible, standards-based system accessible for all types of clinical research. Akaza Research provides OpenClinica Enterprise, a fully supported version of the OpenClinica platform with comprehensive support including installation, training, validation, upgrades, help desk support, customization, systems integration, and more. OpenClinica see www.akazaresearch.com.
Read the full story at http://www.prweb.com/releases/open-source/clinical-trials-software/prweb4115854.htm.
Copyright©2010 Vocus, Inc.
All rights reserved